Resource Login

GEMS is a five-year project funded by the United States Agency for International Development and the U.S. President’s
Emergency Plan for AIDS Relief. GEMS is led by the University of Pittsburgh in partnership with FHI 360,
BARC-Lancet Laboratories, University College London and University of Washington/Fred Hutchinson Cancer Research Center.

GEMS is funded as part of the Microbicide Product Introduction Initiative (MPii), for information on other MPii projects
please review AVAC's PrEPWATCH website.

Primary tabs